Lexacalcitol - CAS 131875-08-6
Catalog number:
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
KH1060 metabolism could be blocked by the cytochrome P450 inhibitor, ketoconazole. KH1060 was not an effective competitor of C24 oxidation of 1alpha,25-(OH)2D3. Certain hydroxylated metabolites of KH1060 retained significant biological activity in vitamin D-dependent reporter gene systems (chloramphenicol acetyltransferase). KH 1060 inhibited PBMC proliferation and decreased TNF-alpha levels in IBD patients and this effect was synergistic with anti-TNF-alpha. VDR protein levels were significantly increased by PBMC treatment with KH 1060 or anti-TNF-alpha or their combination in ulcerative colitis (UC) patients, and decreased in Crohn's disease (CD) patients, treating the cells with KH 1060. A synergistic inhibition was registered combining KH 1060 and anti-TNF, at well-defined concentrations. 0.1 nM KH 1060 produced a significant decrease in TNF-alpha levels, determined by ELISA, although less remarkable than in the presence of anti-TNF.
Publictions citing BOC Sciences Products
  • >> More
KH 106; KH 1060; KH-1060; KH1060
1.Characterization of irritant patch test reactions to topical D vitamins and all-trans retinoic acid in comparison with sodium lauryl sulphate. Evaluation by clinical scoring and multiparametric non-invasive measuring techniques.
Fullerton A1, Serup J. Br J Dermatol. 1997 Aug;137(2):234-40.
The study was a single-centre, double-blind randomized, placebo-controlled within-subject comparison of 42 healthy volunteers. Occlusive patch test for 48 h was performed with solutions of 1 alpha,25(OH)2D3 (calcitriol), two vitamin D analogues (calcipotriol and KH 1060 (lexacalcitol)), all-trans retinoic acid and sodium lauryl sulphate (SLS) as reference irritant. Solution vehicles and an empty chamber was also included. Test evaluation was performed at day 2, day 3 and again on day 7. Test evaluation was based both on clinical scoring and on various non-invasive measuring methods. 1 alpha,25(OH)2D3, calcipotriol and KH 1060 all showed mild irritation in the concentrations tested. The number and severity of test reactions was found to be dose dependent based both on clinical scoring and on non-invasive measurements. Irritation of the vitamin D analogues mainly affected the vasculature with vasodilation and increased cutaneous blood flow.
2.The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activity.
Dilworth FJ1, Williams GR, Kissmeyer AM, Nielsen JL, Binderup E, Calverley MJ, Makin HL, Jones G. Endocrinology. 1997 Dec;138(12):5485-96.
Vitamin D analogs are valuable drugs with established and potential uses in hyperproliferative disorders. Lexacalcitol (KH1060) is over 100 times more active than 1alpha,25-dihydroxyvitamin D3 [1alpha,25-(OH)2D3], as judged by in vitro antiproliferative and cell differentiating assays. The underlying biochemical reasons for the increased biological activity of KH1060 are unknown, but are thought to include 1) metabolic considerations in addition to explanations based upon 2) enhanced stability of KH1060-liganded transcriptional complexes. In this study we explored the in vivo and in vitro metabolism of KH1060. We established by physicochemical techniques the existence of multiple side-chain hydroxylated metabolites of KH1060, including 24-, 24a-, 26-, and 26a-hydroxylated derivatives as well as side-chain truncated forms. KH1060 metabolism could be blocked by the cytochrome P450 inhibitor, ketoconazole. KH1060 was not an effective competitor of C24 oxidation of 1alpha,25-(OH)2D3.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related VD/VDR Products

CAS 72203-93-1 Calcitetrol

(CAS: 72203-93-1)

Calcitetrol is the hormonally active form of vitamin D with three hydroxyl groups. It increases blood calcium levels ([Ca2+]) by promoting absorption of dietary...

(CAS: 233268-78-5)

LG190155 is a moderately potent VDR agonist.

CAS 58050-55-8 24, 25-Dihydroxy VD2

24, 25-Dihydroxy VD2
(CAS: 58050-55-8)

24, 25-Dihydroxy VD2 is a hydroxylated metabolite of Vitamin D2, which is a synthetic analog of Vitamin D.

CAS 55721-11-4 Secalciferol

(CAS: 55721-11-4)

Secalciferol is a metabolite of Vitamin D, a possibly anti-inflammatory steroid which is involved in bone ossification. lt mediates calcium and phosphorus homeo...

CAS 131918-61-1 Paricalcitol

(CAS: 131918-61-1)

Synthetic analog of vitamin D. Antihyperparathyroid.

CAS 55700-58-8 (24S)-24,25-Dihydroxyvitamin D3

(24S)-24,25-Dihydroxyvitamin D3
(CAS: 55700-58-8)

(24S)-24,25-Dihydroxycholecalciferol is an inactive form of vitamin D3 which undergoes various levels of hydroxylation to form active vitamin D3 analogs.

CAS 143032-85-3 1α-Hydroxy VD4

1α-Hydroxy VD4
(CAS: 143032-85-3)

1alpha-Hydroxy VD4 , a 1alpha(OH)D derivative,  can effectively induce the differentiation of monoblastic leukaemia U937, P39/TSU and P31/FUJ cells.

CAS 66791-71-7 Impurity B of Calcitriol

Impurity B of Calcitriol
(CAS: 66791-71-7)

Impurity B of Calcitriol is the hormonally active form of vitamin D, and Calcitriol is the active metabolite of vitamin D3 that activates the vitamin D receptor...

CAS 457048-34-9 1α, 24, 25-Trihydroxy VD2

1α, 24, 25-Trihydroxy VD2
(CAS: 457048-34-9)

1alpha, 24, 25-Trihydroxy VD2 is a vitamin D analog.

CAS 112849-14-6 (24S)-MC 976

(24S)-MC 976
(CAS: 112849-14-6)

(24S)-MC 976 is a Vitamin D3 derivative.

CAS 103656-40-2 Calcitriol Impurities D

Calcitriol Impurities D
(CAS: 103656-40-2)

One of the impurities of Calcitriol, an active metabolite of VD3, could be a agonist of vitamin D receptor.

CAS 103909-75-7 Maxacalcitol

(CAS: 103909-75-7)

Maxacalcitol is non-calcemic vitamin D3 analog and ligand of VDR-like receptors.

CAS 129831-99-8 MC 976

MC 976
(CAS: 129831-99-8)

MC 969 is an analog of the calcemic drug 1α-hydroxyvitamin D3 (1α-OH-D3) in which carbons 25, 26, and 27 in the side chain are incorporated into a cyclopropane ...

CAS 112827-99-3 24R-Calcipotriol

(CAS: 112827-99-3)

24R-Calcipotriol is an impurity of Calcipotriol, which is a ligand of VDR-like receptors.

CAS 112828-09-8 (24R)-MC 976

(24R)-MC 976
(CAS: 112828-09-8)

(24R)-MC 976 is a Vitamin D3 derivative.

CAS 29261-12-9 25,26-Dihydroxyvitamin D3

25,26-Dihydroxyvitamin D3
(CAS: 29261-12-9)

Α hydroxylated metabolite of Vitamin D3

CAS 163018-26-6 3-O-(2-Aminoethyl)-25-hydroxyvitamin D3

3-O-(2-Aminoethyl)-25-hydroxyvitamin D3
(CAS: 163018-26-6)

Vitamin D3 analog.

CAS 126860-83-1 MC 1046

MC 1046
(CAS: 126860-83-1)

MC 1046 is a vitamin D3 analogue with similar effects. Impurity of Calcipotriol, an antipsoriatic.

CAS 112965-21-6 Calcipotriol

(CAS: 112965-21-6)

Calcipotriol, a 1,25-Dihydroxyvitamin D3 analogue, is used as topical treatment for psoriasis.

CAS 32222-06-3 Calcitriol

(CAS: 32222-06-3)

Calcitriol is the hormonally active form of vitamin D.

Chemical Structure

CAS 131875-08-6 Lexacalcitol

Quick Inquiry

Verification code

Featured Items